Only One Week Left! Sign Up to Attend AmSpa’s Northeast Regulatory Workshop Today

February 15, 2016

ONLY ONE WEEK LEFT TO REGISTER! 
New York Med Spas and Medical Aesthetic Physicians: 
Is your medical spa or practice operating legally?
Are you missing out on opportunities to improve your business and become more profitable?
Do you know how to protect yourself, your employees and your business?
Learn how to address these issues and many others at AmSpa’s Northeastern Medical Aesthetics Regulatory Workshop on February 22nd. Focused on regulations and legalities, HIPAA, employment issues and much, much more. Register today; only a few seats remain!
Northeastern Medical Aesthetic Regulatory Workshop
Wilson Elser Law Firm, New York, NY
Monday, February 22nd
Cost: $450 (members save an additional $30 and, if you attended the New York event in October, contact cathy@americanmedspa.org for an additional discount.)
Register and Learn More Today!
Developed specifically for the New York medical aesthetic community, this workshop will be held at Wilson Elser Law Firm in New York, NY, and will feature Alex Thiersch, AmSpa founder and director, as well as AmSpa partner attorney, Allyson Avila, from Wilson Elser. 
All attendees will receive the CME monograph Risk Management for the Practicing Physician from OJM Group, an enduring material certified nationally for 5.5 category 1 CME hours.
Final Agenda
Below is the final agenda for the event. Breakfast, lunch and a cocktail reception will be provided for the event. Register today and save $30 if you are a member. Only a few seats left!
Sponsored by:

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics Debuts AA Signature in the United States with SKIN360
    • Candela Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Approves Additional Warning for Kybella Labeling
    • Federal Bill Would Establish New Ownership and Management Requirements for Medical Practices
    • CBS News Investigation Raises Concerns About Unapproved Retatrutide Sales